4basebio UK Societas Statistics
4basebio UK Societas (88Q) Stock Statistics & Valuation Metrics
Total Valuation
4basebio UK Societas has a market cap or net worth of EUR 120.70M. The enterprise value is EUR 89.85M.
- Market Cap
- EUR 120.70M
- Enterprise Value
- EUR 89.85M
Share Statistics
4basebio UK Societas has 19,234,728 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 19,234,728
- Owned by Insiders
- 6.36%
- Owned by Institutions
- ―
Financial Efficiency
4basebio UK Societas’s return on equity (ROE) is -1.67 and return on invested capital (ROIC) is -59.74%.
- Return on Equity (ROE)
- -1.67
- Return on Assets (ROA)
- -0.57
- Return on Invested Capital (ROIC)
- -59.74%
- Return on Capital Employed (ROCE)
- -0.63
- Revenue Per Employee
- 12.09K
- Profits Per Employee
- -120.75K
- Employee Count
- 140
- Asset Turnover
- 0.06
- Inventory Turnover
- 1.74
Valuation Ratios
The current PE Ratio of 4basebio UK Societas is -4.53. 4basebio UK Societas’s PEG ratio is 0.33.
- PE Ratio
- -4.53
- PS Ratio
- 104.09
- PB Ratio
- 64.18
- Price to FCF
- -4.91
- Price to Operating Cash Flow
- -5.31
- PEG Ratio
- 0.33
Income Statement
In the last 12 months, 4basebio UK Societas had revenue of 1.69M and earned -16.91M in profits. Earnings per share was -1.09.
- Revenue
- 1.69M
- Gross Profit
- 548.00K
- Operating Income
- -16.73M
- Pretax Income
- -17.60M
- Net Income
- -16.91M
- EBITDA
- -15.58M
- Earnings Per Share (EPS)
- -1.09
Cash Flow
In the last 12 months, operating cash flow was -15.36M and capital expenditures -1.21M, giving a free cash flow of -16.57M billion.
- Operating Cash Flow
- -15.36M
- Free Cash Flow
- -16.57M
- Free Cash Flow per Share
- -1.07
Dividends & Yields
4basebio UK Societas pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.39%
- Earnings Yield
- -22.10%
Stock Price Statistics
- Beta
- 0.23
- 52-Week Price Change
- -27.33%
- 50-Day Moving Average
- 6.14
- 200-Day Moving Average
- 5.91
- Relative Strength Index (RSI)
- 27.80
- Average Volume (3m)
- 409
Important Dates
4basebio UK Societas upcoming earnings date is Jun 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 25, 2026
- Next Earnings Date
- Jun 02, 2027
- Ex-Dividend Date
- ―
Financial Position
4basebio UK Societas as a current ratio of 7.31, with Debt / Equity ratio of 163.24%
- Current Ratio
- 7.31
- Quick Ratio
- 7.07
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- 0.08
- Interest Coverage Ratio
- -18.86
Taxes
In the past 12 months, 4basebio UK Societas has paid -698.00K in taxes.
- Income Tax
- -698.00K
- Effective Tax Rate
- 0.04
Enterprise Valuation
4basebio UK Societas EV to EBITDA ratio is -5.54, with an EV/FCF ratio of -5.45.
- EV to Sales
- 115.68
- EV to EBITDA
- -5.54
- EV to Free Cash Flow
- -5.45
- EV to Operating Cash Flow
- -5.88
Balance Sheet
4basebio UK Societas has EUR 14.05M in cash and marketable securities with EUR 23.10M in debt, giving a net cash position of -EUR 9.05M billion.
- Cash & Marketable Securities
- EUR 14.05M
- Total Debt
- EUR 23.10M
- Net Cash
- -EUR 9.05M
- Net Cash Per Share
- -EUR 0.47
- Tangible Book Value Per Share
- -EUR 0.24
Margins
Gross margin is -86.94%, with operating margin of -2232.91%, and net profit margin of -2307.94%.
- Gross Margin
- -86.94%
- Operating Margin
- -2232.91%
- Pretax Margin
- -2378.36%
- Net Profit Margin
- -2307.94%
- EBITDA Margin
- -2086.81%
- EBIT Margin
- -2232.91%
Analyst Forecast
The average price target for 4basebio UK Societas is EUR 11.99, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 11.99
- Price Target Upside
- 104.89% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- -57.54%
- EPS Growth Forecast
- -12.93%
Scores
- Smart Score
- 8
- AI Score
- ―

